Recovery After Surgery Extends Beyond Physical Healing
For many patients, breast cancer surgery marks the beginning of recovery rather than the end of treatment. While the focus often centers on surgical outcomes and cancer care, emotional health during the days surrounding surgery can significantly influence the overall recovery experience. Anxiety, depression, poor sleep, and pain frequently overlap during this period, making recovery more challenging.
A new randomized clinical trial suggests that perioperative depression treatment using transcranial direct current stimulation (tDCS) may help patients recover more comfortably during the earliest stages after breast cancer surgery. The findings add to growing interest in nonpharmacological neuromodulation techniques that complement traditional medical care.
The Challenge Of Treating Depression Around Surgery
Perioperative depression is common among patients facing cancer surgery. Emotional distress can affect motivation, sleep, pain perception, rehabilitation, and overall quality of life. Although medications and psychological support remain important treatment options, they are not always ideal during the immediate postoperative period, when concerns about medication interactions, side effects, and recovery are heightened.
This has encouraged researchers to investigate whether brain stimulation therapies could safely support emotional recovery without adding another medication to the treatment plan.
How Perioperative Depression Treatment With tDCS Was Studied
Researchers at Xuzhou Central Hospital in China conducted a randomized clinical trial involving 64 adults undergoing elective breast cancer surgery.
Participants were randomly assigned to receive either active tDCS or a sham treatment. The stimulation targeted the left dorsolateral prefrontal cortex, a brain region frequently associated with mood regulation and executive function.
Patients completed two stimulation sessions beginning one day before surgery and continuing daily through the fifth postoperative day. Investigators evaluated depressive symptoms, sleep quality, postoperative pain, and adverse events both five days after surgery and again one month later.
The randomized, sham-controlled design strengthens confidence that the observed improvements were associated with the intervention rather than patient expectations alone.
Early Improvements Suggest Meaningful Recovery Benefits
The primary outcome focused on depressive symptoms measured with the 17-item Hamilton Depression Rating Scale.
By the fifth postoperative day, patients receiving active tDCS demonstrated significantly lower depression scores compared with those receiving sham stimulation. Participants in the active group also reported lower postoperative pain scores and better sleep quality.
Another notable finding involved postoperative nausea and vomiting, which occurred less frequently among patients receiving active stimulation.
Interestingly, differences between the groups were no longer statistically significant one month after surgery. Rather than indicating that tDCS stopped working, researchers noted that patients in the sham group continued improving over time, eventually reaching similar recovery levels.
This pattern suggests that tDCS may accelerate recovery during the period when patients are most vulnerable instead of producing permanent differences in long-term outcomes.
Why Brain Stimulation May Influence Recovery
Transcranial direct current stimulation delivers a low-intensity electrical current through electrodes placed on the scalp. Unlike more intensive forms of neuromodulation, tDCS does not directly trigger neuronal firing. Instead, it subtly alters the excitability of brain networks involved in emotional processing and cognitive regulation.
By stimulating the left dorsolateral prefrontal cortex, clinicians aim to strengthen activity within circuits commonly associated with depression while improving communication across broader mood-regulating networks.
Researchers also believe these neural effects may indirectly influence pain perception, sleep regulation, and stress responses, helping explain why improvements extended beyond depressive symptoms alone.
A Growing Role For Nonpharmacological Neuromodulation
Although tDCS remains an emerging therapy, studies like this highlight its potential as a practical adjunct to standard perioperative care.
The treatment is portable, relatively inexpensive, noninvasive, and generally well tolerated. Rather than replacing established psychiatric or surgical care, it may provide additional support during the critical first week after surgery when emotional distress, pain, and sleep disruption often intersect.
Larger multicenter trials will be needed to determine which patients benefit most, whether similar results occur in other surgical populations, and how treatment protocols can be optimized.
Still, these findings contribute to the expanding body of evidence supporting neuromodulation as an important area of investigation within interventional psychiatry. As researchers continue exploring ways to improve recovery beyond the operating room, therapies like tDCS may become valuable tools for supporting both emotional and physical healing during cancer treatment.
Citations
Transcranial Direct Current Stimulation for Perioperative Depression in Breast Cancer Surgery: A Randomized Controlled Trial. PubMed Abstract
International Federation of Clinical Neurophysiology. Lefaucheur JP, et al. Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clinical Neurophysiology. 2017. https://www.clinph-journal.com/article/S1388-2457(16)31236-5/fulltext